Equitable Trust CO Abb Vie Inc. Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Equitable Trust CO holds 34,226 shares of ABBV stock, worth $6.16 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

34,226

Previous 31,528 8.56%

Holding current value

$6.16 Million

Previous $5.41 Million 24.99%

% of portfolio

0.46%

Previous 0.39%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $442,040 - $537,792	2,698 Added 8.56%	34,226 $6.76 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $148,598 - $173,529	960 Added 3.14%	31,528 $5.41 Million
Q1 2024 Apr 25, 2024	BUY	$159.82 - $182.1 $225,825 - $257,307	1,413 Added 4.85%	30,568 $5.57 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $506,505 - $570,444	3,681 Added 14.45%	29,155 $4.52 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $82,425 - $95,419	617 Added 2.48%	25,474 $3.8 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $63,737 - $79,316	-481 Reduced 1.9%	24,857 $3.35 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $57,554 - $66,282	-398 Reduced 1.55%	25,338 $4.04 Million
Q4 2022 Feb 21, 2023	BUY	$138.31 - $165.87 $123,095 - $147,624	890 Added 3.58%	25,736 $4.16 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $71,802 - $82,352	535 Added 2.2%	24,846 $3.34 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $185,511 - $235,846	1,348 Added 5.87%	24,311 $3.72 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $619,250 - $768,315	4,692 Added 25.68%	22,963 $3.72 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $136,650 - $172,902	-1,272 Reduced 6.51%	18,271 $2.47 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $226,738 - $257,382	-2,131 Reduced 9.83%	19,543 $2.11 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $474,497 - $528,617	-4,510 Reduced 17.22%	21,674 $2.44 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $283,371 - $311,957	-2,770 Reduced 9.57%	26,184 $2.83 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $40,486 - $54,661	503 Added 1.77%	28,954 $3.1 Million
Q2 2020 Aug 18, 2020	BUY	$73.37 - $98.18 $10,932 - $14,628	149 Added 0.53%	28,451 $2.79 Million
Q1 2020 May 21, 2020	SELL	$64.5 - $97.79 $166,345 - $252,200	-2,579 Reduced 8.35%	28,302 $2.16 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $281,162 - $351,794	-3,898 Reduced 11.21%	30,881 $2.73 Million
Q3 2019 Nov 19, 2019	BUY	$62.98 - $75.72 $898,409 - $1.08 Million	14,265 Added 69.54%	34,779 $2.63 Million
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $264,573 - $338,187	-4,027 Reduced 16.41%	20,514 $1.49 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $17,742 - $20,881	230 Added 0.95%	24,541 $1.98 Million
Q4 2018 Feb 22, 2019	SELL	$77.85 - $96.01 $15,102 - $18,625	-194 Reduced 0.79%	24,311 $2.24 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $765,781 - $851,308	8,613 Added 54.2%	24,505 $2.32 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.43 Million - $1.69 Million	15,892 New	15,892 $1.47 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Abb Vie Inc. Transaction History